echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Intens Care Med: Distal ischemic adaptation in patients with septic shock

    Intens Care Med: Distal ischemic adaptation in patients with septic shock

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Septic shock is one of the most serious complications of all infections, affecting millions of people
    each year.


    Recently, a research article was published in Intensive Care Medicine, an authoritative journal in critical care medicine, the purpose of which was to determine whether distal ischemic adaptation (RECO) improves the severity and outcome
    of multi-organ failure in patients with septic shock compared with standard treatment.


    The RECOO-sepsis trial was a prospective, multicenter, randomized, open-label, parallel trial of adult patients in septic shock in six intensive care units in France
    .


    Of the 180 randomized patients, 178 completed the trial (RECO group: 87; Control group: 91), and incorporating an intent-to-treat analysis (108 males [60.


    In patients with septic shock, from inclusion to day 4, RECO failed to reduce the severity of organ failure by average daily SOFA score.


    Original Source:

    Martin Cour.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.